Preferred Pharmaceuticals — Class II drug recall D-0769-2022
Terminated recall by Preferred Pharmaceuticals, Inc., reported 2022-04-20, distributed nationwide. Out of specification results observed in dissolution during long term stability testing.
| Recall number | D-0769-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2022-03-28 |
| Classified | 2022-04-14 |
| Reported by FDA | 2022-04-20 |
| Terminated | 2022-05-10 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 68788-6390-09 |
| Lot numbers | D1321X, D2221J, D3021T, H0221R |
| Expiration dates | 2023-12-31 |
Product
Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09
Reason for recall
Out of specification results observed in dissolution during long term stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0769-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.